← Back
$ALMR All transactions

Alamar Biosciences, Inc.

C

$ Value

$0

Shares

6,404,332

Price

$0

Filed

Apr 22

Insider

Name

Qiming Corporate GP VI, Ltd.

Title

CIK

0002059127

Roles

10% Owner

Transaction Details

Transaction Date

2026-04-20

Code

C

Table

Derivative

Ownership

Indirect

Equity Swap

No

Shares After

Footnotes

Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date. | Each share of Series B Preferred Stock converted into 0.4403 share of Class B Common Stock at the closing of the initial public offering. The Series B Preferred Stock had no expiration date. | These shares are held of record by Qiming Managing Directors Fund VI, L.P. ("Qiming Managing Directors"). Qiming Corporate GP VI, Ltd. ("Qiming Corporate") serves as the general partner of Qiming Managing Directors and may be deemed to have voting and dispositive power over the shares held by Qiming Managing Directors. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. | These shares are held of record by Qiming Venture Partners VI, L.P., ("Qiming Venture Partners VI"). Qiming Corporate, through one intermediary, serves as the indirect general partner of Qiming Venture Partners VI and may be deemed to have voting and dispositive power over the shares held by Qiming Venture Partners VI. Qiming Corporate disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. | These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. | These shares are held of record by Qiming Venture Partners VIII-HC, L.P. ("QVP VIII-HC"). Qiming GP VIII-HC, LLC serves as the general partner of QVP VIII-HC and may be deemed to have voting and dispositive power over the shares held by QVP VIII-HC. Qiming GP VIII-HC, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein. | Each share of Class B Common Stock was automatically reclassified into one share of Common Stock immediately prior to the completion of the Issuer's initial public offering of Common Stock.

Filing Info

Accession No.

0001231919-26-000392

Form Type

4

Issuer CIK

0002104204

Qiming Corporate GP VI, Ltd.'s History

Date Ticker Type Value
2026-04-20 ALMR C
2026-04-20 ALMR C
2026-04-20 ALMR C
2026-04-20 ALMR C
2026-04-20 ALMR J
2026-04-20 ALMR J
2026-04-20 ALMR J
2026-04-20 ALMR J
2026-04-20 ALMR J
2026-04-20 ALMR J

Other Insiders at ALMR (90d)

Insider Bought Sold Last
Illumina Innovation Fund II GP, L.L.C. / Naclerio Nicholas $4.0M 2026-04-20
Witney Frank 2026-04-20
Naclerio Nicholas 2026-04-20
Illumina Innovation Fund II GP, L.L.C. 2026-04-20
McAnear Justin J.
Chief Financial Officer
2026-04-20
Chambers Rebecca 2026-04-20
Qiming Corporate GP VI, Ltd. 2026-04-20
White Timothy Ogden
President
2026-04-20
Luo Yuling
Chief Executive Officer
2026-04-20
Chen Shiping
Chief Operating Officer
2026-04-20